Minimal mesangial glomerulonephritis
[[File:<!|thumb|<!]] Minimal mesangial glomerulonephritis is a type of glomerulonephritis, which is a group of diseases that injure the part of the kidney that filters blood (called glomeruli). This condition is characterized by minimal changes in the mesangial cells and matrix, which are part of the glomeruli.
Pathophysiology[edit | edit source]
Minimal mesangial glomerulonephritis involves the mesangial cells, which are specialized cells in the glomerulus that help regulate blood filtration. In this condition, there is a slight increase in the number of mesangial cells and the amount of mesangial matrix, but these changes are minimal and often only detectable under a microscope with special staining techniques.
Clinical Presentation[edit | edit source]
Patients with minimal mesangial glomerulonephritis may present with hematuria (blood in the urine), proteinuria (protein in the urine), or both. The condition can be asymptomatic or present with mild symptoms. It is often discovered incidentally during routine urine tests.
Diagnosis[edit | edit source]
The diagnosis of minimal mesangial glomerulonephritis is typically made through a combination of clinical evaluation, laboratory tests, and a kidney biopsy. The biopsy is essential for confirming the diagnosis, as it allows for the examination of the glomeruli under a microscope.
Treatment[edit | edit source]
Treatment for minimal mesangial glomerulonephritis depends on the severity of the symptoms and the underlying cause. In many cases, the condition may not require specific treatment and can be managed with regular monitoring. If there is significant proteinuria or other complications, treatment may include medications such as angiotensin-converting enzyme inhibitors (ACE inhibitors) or angiotensin II receptor blockers (ARBs) to reduce proteinuria and protect kidney function.
Prognosis[edit | edit source]
The prognosis for minimal mesangial glomerulonephritis is generally good, especially if the condition is detected early and managed appropriately. Most patients do not progress to more severe forms of kidney disease.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD